NAPROGENIX, INC.

Address

UK-ASTECC 145 Graham Avenue
Lexington, KY, 40506-0001

http://www.naprogenix.com

Information

DUNS: 196165877
# of Employees: 8

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. Harvesting specific plant metabolites from hairy root cultures using magnetized nanoparticles

    Amount: $530,326.00

    Abstract Plant cell cultures are becoming a commercially valuable source of pharmaceuticals particularly those that are too complex for economical chemical synthesis For example Phyton Biotech in ...

    SBIRPhase II2017Department of Health and Human Services National Institutes of Health
  2. Mutant transgenic plant cells as a novel source of drugs

    Amount: $455,773.00

    Abstract The objective is further development of a biotechnology that evolves biosynthesis in a plant species toward bioactive metabolites with a specific molecular target In wild type plants bioa ...

    SBIRPhase II2016Department of Health and Human Services
  3. IGF OT IGF POTENTIAL COMMERCIALIZATION OF PROPRIETARY COMPOUND JR

    Amount: $285,767.00

    alcohol

    SBIRPhase II2016Department of Health and Human Services
  4. Novel flavonoids as anti-inflammatory agents in alcoholism

    Amount: $150,900.00

    DESCRIPTION (provided by applicant): Flavonoids are ubiquitous secondary metabolites in plants with many known health benefits, which are mostly ascribed to their potent anti-oxidant activity. Howev ...

    SBIRPhase I2014Department of Health and Human Services
  5. Harvesting specific plant metabolites from hairy root cultures using magnetized n

    Amount: $189,844.00

    DESCRIPTION: Plants produce a wide variety of valuable bioactive metabolites, but these are commonly present in low concentrations in the wild-type plant. This makes the separation and purification o ...

    STTRPhase I2014Department of Health and Human Services
  6. Selection-driven plant metabolites for treatment of CNS diseases

    Amount: $1,019,366.00

    DESCRIPTION (provided by applicant): This project aims to demonstrate that the evolution of plant biosynthetic pathways can be accelerated and driven to favor the synthesis of ligands which interact w ...

    SBIRPhase II2013Department of Health and Human Services
  7. Selection-driven plant metabolites for treatment of CNS diseases

    Amount: $1,102,755.00

    DESCRIPTION provided by applicant This project aims to demonstrate that the evolution of plant biosynthetic pathways can be accelerated and driven to favor the synthesis of ligands which interact w ...

    SBIRPhase II2013Department of Health and Human Services
  8. NOVEL PHARMACOTHERAPIES FOR ALCOHOLISM, TOPIC #4409/24/2012- 03/23/2013

    Amount: $149,697.00

    Alcoholism is a complex condition in which there are many potential molecular and therapeutic targets for pharmacotherapy. This fast track SBIR contract aims to investigate compounds targeted on t ...

    SBIRPhase I2012Department of Health and Human Services
  9. Selection-driven plant metabolites for treatment of CNS diseases

    Amount: $272,674.00

    DESCRIPTION (provided by applicant): The primary aim is to transfer a biotechnology platform for plant drug discovery from the academic laboratory to industry use (i.e. this application is directly re ...

    SBIRPhase I2010Department of Health and Human Services
  10. Novel estrogen receptor ligands from plant genomics

    Amount: $699,216.00

    DESCRIPTION (provided by applicant): Human nuclear receptor (HNR) ligands have potential value as pharmacotherapies or chemopreventive agents for many hormone-responsive cancers. The primary aim of th ...

    STTRPhase II2010Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government